The Department of Defense, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), intends to award a modification to the existing contract HT942523D0018 on a sole source basis to Trillamed LLC. The primary objectives of this contract modification include the replacement of biocontainment sterilizer units, which involves the removal and disposal of existing units, as well as the installation of new units with biocontainment bioseal, certification, and validation, along with upgrading the software operating controls of existing pass-through biocontainment autoclaves. This procurement is critical for maintaining the operational integrity and safety of biocontainment facilities at the U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID). Interested vendors may submit capability statements by 1300 Eastern Time on August 10, 2025, via email to Kirstin.L.Quinn.civ@health.mil and Emily.k.ohara.civ@health.mil, as no solicitation document exists for this requirement.